Ebola vaccine trial to start in DR Congo as warning issued over speed of infections
About half of the 2,500 recorded deaths from Ebola happened in the last 20 days, the WHO says.
The Democratic Republic of the Congo is preparing to launch an Ebola vaccine trial, with some doses being used in a trial to determine its effectiveness against the Bundibugyo species of the virus currently circulating in the country. The Ervebo vaccine, which also protects against the Zaïre species of Ebola, currently has no proven treatments for Bundibugyo.
This comes as the World Health Organization (WHO) issued a warning that Ebola is growing exponentially in the north and east of DR Congo, spreading to an area larger than France. Over 2,500 people have died in this outbreak, which began three months ago; half of these deaths occurred in the last 20 days. WHO Ebola co-ordinator Julien Harneis stated that the outbreak is growing faster and wider than the Ebola response itself.
Written by urgent.news from BBC World's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
